Pharming Group N.V. - ADR

NASDAQ:PHAR 3:59:44 PM EDT

14.60

+0.70 (+5.04%)

4:30:03 PM EDT: $14.65 +0.05 (+0.34%)

Market Cap (Intraday)	1.00B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$98.22 Million
Adjusted EPS	$0.00

See more estimates

10-Day MA	$14.30
50-Day MA	$12.24
200-Day MA	$10.03

See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.